Literature DB >> 28707183

Downregulation of iNOS and elevation of cAMP mediate the anti-inflammatory effect of glabridin in rats with ulcerative colitis.

Nahla E El-Ashmawy1, Naglaa F Khedr1, Hoda A El-Bahrawy1, Samar A El-Adawy2.   

Abstract

BACKGROUND: Alternative medicine is widely accepted by public and becoming an attractive approach for treatment of various diseases. Glabridin (Gla), a major flavonoid present in licorice root, was reported to have antioxidant and anti-inflammatory properties.
OBJECTIVE: The study aimed to investigate the possible protective role of Gla against dextran sulphate sodium (DSS)-induced ulcerative colitis (UC) in rats and to clarify the molecular mechanisms underlying Gla function.
METHODS: Forty male Wistar rats were divided into control, colitis group (rats received 5% DSS in drinking water for 7 days), Gla group (50 mg/kg, orally, once daily), and sulfasalazine (SLZ) group (500 mg/kg, orally, once daily). Each of Gla and SLZ was administered 1 week ahead of DSS and parallel with its administration.
RESULTS: Gla ameliorated the inflammatory alterations induced by DSS. Gla group showed a reduction in colon concentration of tumor necrosis factor-alpha (TNF-α) and a decreased colon myeloperoxidase activity (MPO). Gla treatment downregulated inducible nitric oxide synthase (iNOS) gene expression in rat colon with a decreased content of nitric oxide (NO). Gla also increased cyclic AMP (cAMP) concentration in rat colon compared to colitis group. Such findings were comparable to or even better than those obtained by SLZ treatment. The histological features of UC such as ulceration and inflammatory cell infiltrations were improved in rat group treated by Gla.
CONCLUSION: Gla proved a potent anti-inflammatory role in UC through different mechanisms and, being a natural product, it could be safely used as a protective measure in inflammatory bowel diseases.

Entities:  

Keywords:  CAMP; Glabridin; INOS; Myleoperoxidase; TNF-α; Ulcerative colitis

Mesh:

Substances:

Year:  2017        PMID: 28707183     DOI: 10.1007/s10787-017-0373-9

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  42 in total

Review 1.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

Review 2.  Nitric oxide in inflammatory bowel disease.

Authors:  Raymond K Cross; Keith T Wilson
Journal:  Inflamm Bowel Dis       Date:  2003-05       Impact factor: 5.325

Review 3.  Inflammatory bowel disease related innate immunity and adaptive immunity.

Authors:  Yuan Huang; Zhonge Chen
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

Review 4.  Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease.

Authors:  Klaus F Rabe
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

5.  Dual inhibitory effect of Glycyrrhiza glabra (GutGard™) on COX and LOX products.

Authors:  C V Chandrasekaran; H B Deepak; P Thiyagarajan; S Kathiresan; Gopal Krishna Sangli; M Deepak; Amit Agarwal
Journal:  Phytomedicine       Date:  2010-09-22       Impact factor: 5.340

6.  Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis.

Authors:  Ali Mustafa; Azza El-Medany; Hanan H Hagar; Gamila El-Medany
Journal:  Pharmacol Res       Date:  2006-02-03       Impact factor: 7.658

7.  Inhibitory effects of flavonoids extracted from licorice on lipopolysaccharide-induced acute pulmonary inflammation in mice.

Authors:  Yi-Cheng Xie; Xin-Wei Dong; Xi-Mei Wu; Xiao-Feng Yan; Qiang-Min Xie
Journal:  Int Immunopharmacol       Date:  2008-12-09       Impact factor: 4.932

8.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

9.  Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells.

Authors:  Ming-Ju Hsieh; Chiao-Wen Lin; Shun-Fa Yang; Mu-Kuan Chen; Hui-Ling Chiou
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  Experimental Models of Inflammatory Bowel Diseases.

Authors:  Patricia Kiesler; Ivan J Fuss; Warren Strober
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-03-01
View more
  7 in total

1.  Metabolic Profiling of Glabridin in Rat Plasma, Urine, Bile, and Feces After Intragastric and Intravenous Administration.

Authors:  Shundi Liu; Hao Lin; Yu Chen; Yuzhen Wang; Xiaoshan Zhang; Zheng Xiang; Xiaojun Cai
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-09-15       Impact factor: 2.569

2.  CD26 Deficiency Controls Macrophage Polarization Markers and Signal Transducers during Colitis Development and Resolution.

Authors:  Iva Vukelic; Suncica Buljevic; Lara Baticic; Karmela Barisic; Barbara Franovic; Dijana Detel
Journal:  Int J Mol Sci       Date:  2022-05-14       Impact factor: 6.208

3.  Protective Effect of Spirulina platensis Extract against Dextran-Sulfate-Sodium-Induced Ulcerative Colitis in Rats.

Authors:  Mohamed A Morsy; Sumeet Gupta; Anroop B Nair; Katharigatta N Venugopala; Khaled Greish; Mahmoud El-Daly
Journal:  Nutrients       Date:  2019-09-29       Impact factor: 5.717

Review 4.  Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids.

Authors:  Yufan Wu; Zhuxian Wang; Qunqun Du; Zhaoming Zhu; Tingting Chen; Yaqi Xue; Yuan Wang; Quanfu Zeng; Chunyan Shen; Cuiping Jiang; Li Liu; Hongxia Zhu; Qiang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-17       Impact factor: 2.629

Review 5.  Traditional Chinese medicine prescription Shenling BaiZhu powder to treat ulcerative colitis: Clinical evidence and potential mechanisms.

Authors:  Jing Chen; Bixin Shen; Zhengli Jiang
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

6.  Self-Assembled pH-Responsive Metal-Organic Frameworks for Enhancing the Encapsulation and Anti-Oxidation and Melanogenesis Inhibition Activities of Glabridin.

Authors:  Liang Chen; Zexun Liu; Xinying Zhao; Linying Liu; Xiulan Xin; Hao Liang
Journal:  Molecules       Date:  2022-06-18       Impact factor: 4.927

7.  Glabridin Plays Dual Action to Augment the Efficacy and Attenuate the Hepatotoxicity of Methotrexate in Arthritic Rats.

Authors:  Ashish Dogra; Dilpreet Kour; Mahir Bhardwaj; Sumit Dhiman; Amit Kumar; Bhavna Vij; Ajay Kumar; Utpal Nandi
Journal:  ACS Omega       Date:  2022-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.